Markets

Insider Trading

Hedge Funds

Retirement

Opinion

20 Countries With Highest Rates of Cancer

In this article, we’ll take a detailed look at the 20 countries with the highest rates of cancer. For a quick overview of the top five countries, read our article 5 Countries With Highest Rates of Cancer.

Cancer, a pervasive and devastating disease, leaves a profound global impact. Also known as malignant tumors or neoplasms, cancer encompasses a wide array of illnesses that can emerge in various parts of the body. One of its defining features is the rapid growth of abnormal cells that surpass their normal limits, infiltrating nearby tissues and possibly metastasizing to other organs. The World Health Organization (WHO) reports that cancer remains a leading cause of death worldwide, responsible for nearly 10 million deaths in 2020, accounting for almost one in six deaths globally. In addition, the World Cancer Research Fund estimates that 18,094,716 million cases of cancer were diagnosed that same year. When considering all cancers (excluding non-melanoma skin cancer) and combining data for both men and women, the age-standardized rate was 190 cases per 100,000 individuals. Notably, this rate was higher among men, with 206.9 cases per 100,000, compared to women, who had a rate of 178.1 cases per 100,000 individuals. In the global context, Europeans are disproportionately affected by cancer. While Europeans make up only one-tenth of the world population, about 25% of all annual cancer cases occur in Europe.

The field of oncology represents a vast and swiftly expanding domain within biopharmaceutical research and development (R&D). According to Precedence Research, the global oncology market surpassed an impressive value of $203 billion in 2022, and it is estimated to continue growing with a compound annual growth rate (CAGR) of 8.8% until 2032, reaching a significant value of $470.61 billion. Notably, within this growth trajectory, the hospital segment is projected to experience even more rapid expansion, with a forecasted CAGR of 10.9% during the specified period.

See also: 25 Best Hospitals for Cancer Treatment in the World

On the other hand, the field of cancer vaccines has also gained significant global attention. Cancer treatment vaccines differ from the vaccines designed to combat viruses. The primary goal of cancer treatment vaccines is to stimulate the immune system to target and attack cancer cells present within the body. Unlike preventive vaccines that aim to stop diseases from occurring, cancer treatment vaccines are intended to trigger an immune response against an existing disease, encouraging the immune system to combat and potentially eradicate cancerous cells. Merck & Co., Inc. (NYSE:MRK) and Moderna, Inc. (NASDAQ:MRNA) have joined forces to develop a promising vaccine, combining an mRNA cancer vaccine with Moderna’s Keytruda®. On July 26, the companies announced that the enrollment of patients had commenced for a late-stage clinical trial. Promising results from a mid-stage study involving 157 patients revealed that the combination of the vaccine and Keytruda significantly reduced the risk of recurrence or death by 44% in individuals with melanoma, the most fatal type of skin cancer, compared to the use of Keytruda alone. The progress in these areas showcases the increasing promise and dedication to enhancing cancer treatment using innovative vaccine strategies. If you’re interested in learning more information about companies engaged in oncology and vaccine development, our list of the 11 Most Promising Cancer Stocks According to Analysts provides valuable insights.

Our Methodology

For our list of the countries with the highest rates of cancer, we used the 2020 data from the World Cancer Research Fund which recorded the number of cancer cases across the globe. The countries on this list are ranked according to the cancer incidence rates per 100,000 individuals for that year.

20. Germany

Cancer Incidence Rate: 281.9

In 2019, approximately 231,000 individuals succumbed to cancer in Germany, with 125,000 being men and 106,000 being women. The Federal Statistical Office (Destatis) highlights that a quarter of all deaths in the country during that period were attributed to cancer. Remarkably, this proportion remained nearly constant over a span of 20 years, despite a 10% increase in the number of cancer-related deaths compared to the figures recorded in 1999.

19. Japan

Cancer Incidence Rate: 282.9

Cancer is the most common cause of death for Japanese people who are 40 and over. According to a Ministry of Health, Labor, and Welfare report, in the year 2020, Japan saw a total of 378,356 cancer-related deaths, constituting 27.6% of all deaths that year, which means one out of every four deaths was due to cancer. The cancer death rate, measured as the number of deaths per 100,000 individuals, showed a steady increase, reaching 307.0 in 2020. For men, the highest death rate from cancer was attributed to lung cancer, causing 53,244 deaths, while the most prevalent cause of cancer-related death among women, with 24,069 deaths, was colorectal cancer.

18. Croatia

Cancer Incidence Rate: 284.1

Despite spending more than the EU average on cancer treatment, Croatia’s cancer mortality rate remains significantly elevated. While it ranks among the countries with the highest cancer rates, the country also has the second-highest cancer mortality rate among European Union (EU) countries, after Hungary, exceeding the EU average by 25%. According to WCRF statistics, Croatia recorded 25,001 cancer cases in 2020.

17. Canada

Cancer Incidence Rate: 287.4

Cancer is the leading cause of death in Canada, and 43% of all people in the country are expected to receive a cancer diagnosis in their lifetime. A recent study published in the Canadian Medical Association Journal (CMAJ) reveals that although overall cancer rates in Canada are on a decline, the number of cases and deaths is showing a slight increase due to factors like population growth and an aging population. The study, conducted collaboratively by the Canadian Cancer Society, Statistics Canada, and the Public Health Agency of Canada, projects an estimated 233,900 new cancer cases and 85,100 cancer-related deaths in Canada for the year 2022. This marks an increase from the estimated figures of 229,200 cancer cases and 84,600 cancer deaths in the year 2021.

16. Lithuania

Cancer Incidence Rate: 287.5

Cancer stands as the second leading cause of death in Lithuania. Among all cancer-related deaths, lung, colorectal, and stomach cancers are the most commonly reported causes. Based on the estimates by the European Commission’s Joint Research Centre, Lithuania was projected to experience approximately 16,600 new cancer cases and over 8,000 cancer-related deaths in 2020. The overall cancer mortality rate in Lithuania was expected to surpass the EU average.

15. Slovakia

Cancer Incidence Rate: 290.4

Cancer mortality remains alarmingly high in Slovakia. Lung and colorectal cancer stand out as the most prevalent causes of cancer-related deaths among the Slovak population, despite witnessing slight reductions in mortality rates since the year 2000. Nearly 30 000 new cases of
cancer were recorded in Slovakia in 2020. Although the country implemented a national cancer plan in 2018, whose primary objectives were to lower the incidence of cancer cases, reduce cancer-related mortality rates, and enhance the overall quality of life for patients affected by oncological diseases, nearly 13,700 individuals succumbed to cancer in Slovakia, placing the country second in the EU in terms of cancer mortality in 2019.

14. Serbia

Cancer Incidence Rate: 291.6

Ranking high among the countries with the highest rates of cancer, central Serbia reported nearly 30,000 new cancer cases, excluding the autonomous regions of Kosovo and Vojvodina, which was a significant increase from 19,000 cases recorded in 1999. Despite advancements in treatment options, the death toll in 2018 reached 15,500, as opposed to 12,000 in 1999. According to the 2020 statistics, Serbia recorded almost 50,000 instances of cancer, out of a population of nearly 7 million.

13. New Zealand

Cancer Incidence Rate: 295.3

In New Zealand (Aotearoa), approximately 25,000 people receive a cancer diagnosis each year, with almost 3,000 of those individuals being Māori. The most commonly diagnosed cancers include breast, lung, prostate, and colorectal cancers. However, cancer incidence patterns have shown changes over time, with some types, such as stomach and lung cancers, decreasing, while others, like liver and pancreatic cancers, are on the rise. Lung cancer and colorectal cancer contribute to the highest number of cancer-related deaths each year, accounting for around 1,700 and 1,200 fatalities, respectively. However, the country has seen substantial improvements in cancer survival rates over the past two decades, resulting in more people overcoming the disease.

12. Latvia

Cancer Incidence Rate: 296.1

Latvia faces considerable cancer incidence rates, as indicated by data from the European Cancer Information System (ECIS) of the Joint Research Centre. Based on pre-pandemic incidence trends, it was estimated that nearly 12,400 new cancer cases would be diagnosed in 2020. The age-standardized rate of new cancer cases per 100,000 population that year was was 606, which is approximately 7% higher than the EU average of 569 per 100,000 population. Prostate cancer was expected to have the highest number of new cases, with 219 per 100,000 population, followed by breast cancer (109 per 100,000 population), colorectal cancer (87 per 100,000 population), and lung cancer (60 per 100,000 population).

11. United Kingdom

Cancer Incidence Rate: 296.1

Cancer remains a significant health issue in the UK, with a substantial number of new cases being diagnosed each year. According to a recent analysis conducted by Cancer Research UK, it is projected that over 500,000 people in the United Kingdom will receive cancer diagnoses annually by the year 2040. This represents a one-third increase from the current average 384,000 cases diagnosed each year, reaching a total of 506,000 new cases annually, surpassing half a million for the first time. While there are positive aspects, such as anticipated reductions in mortality rates for several cancer types, the absolute number of deaths is expected to rise by nearly a quarter to reach 208,000. The report predicts a total of approximately 8.4 million new cancer cases and an estimated 3.5 million cancer-related deaths between 2023 and 2040.

10. United States

Cancer Incidence Rate: 297.3

One of the countries suffering from high cancer rates, it is projected that around 1.9 million new cancer cases will be diagnosed in the United States in 2023.  Furthermore, the American Cancer Society predicts that approximately 609,820 individuals in the United States will lose their lives to cancer in 2023, equivalent to approximately 1670 deaths per day. In terms of gender-specific statistics, the leading causes of cancer-related deaths in men are expected to be lung, prostate, and colorectal cancers. On the other hand, for women, the most significant causes of death are projected to be lung, breast, and colorectal cancers.

9. Slovenia

Cancer Incidence Rate: 300.2

In the 1960s, Slovenia took a significant step by establishing its national cancer registry, which proved instrumental in monitoring cancer incidence across the country. However, during the 1990s, a concerning rise in cervical cancer rates drew attention from experts and prompted the implementation of ZORA, Slovenia’s national cervical cancer screening program. According to the WCRF, more than 13,000 cancer incidences were reported in 2020.

8. Norway

Cancer Incidence Rate: 312.3

In Norway, one out of every three individuals below the age of 75 has received at least one cancer diagnosis. Across the entire population, the number of people with cancer in their medical history has now reached almost 300,000. Between 2017 and 2021, the age group with the highest cancer incidence in Norway was 70 to 74 years. Within this age group, the cancer incidence rate was higher in men compared to women. Specifically, the incidence rate for men was 19.1%, while for women, it was 14.3%.

7. Australia

Cancer Incidence Rate: 312.3

Cancer continues to be a significant contributor to illness and mortality in Australia. The estimated figures for 2021 indicate that approximately 151,000 Australians will receive a cancer diagnosis (equivalent to 413 cases per day), while 49,000 individuals are expected to lose their lives to cancer (equivalent to 135 deaths per day). In terms of cancer diagnosis, breast cancer is the most prevalent, closely followed by prostate cancer. However, when considering cancer-related mortality in 2021, lung cancer was projected to cause more deaths than any other cancer type, with colorectal cancer ranking second in terms of fatalities.

6. The Netherlands

Cancer Incidence Rate: 315.1

According to data collected by the OECD on behalf of the European Commission, the annual death rate for cancer patients in the Netherlands is higher than the European average, with the country also recording one of the highest rates of cancer in Europe. The findings also revealed that Dutch men had a higher likelihood of being diagnosed with cancer compared to Dutch women, with 759 new cases per 100,000 people for men and 577 for women. Similarly to trends across Europe, the most common cancers in the Netherlands include prostate, breast, colorectal (colon), and lung cancers, with the latter three also being the primary causes of death among cancer patients.

Click to continue reading and see the 5 Countries With Highest Rates of Cancer.

Suggested Articles:

Disclosure: None. 20 Countries With Highest Rates of Cancer is originally published on Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…